CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder

Journal of Neurochemistry

Volumn 66, Issue 4, 1996, Pages 1610-1616

  Akiyoshi, Jotaro ^a   Moriyama, Tamie ^a   Isogawa, Koichi ^a   Miyamoto, Masafumi ^a   Sasaki, Ichiro ^a   Kuga, Kiyomi ^a   Yamamoto, Hisao ^a   Yamada, Kenji ^a   Fujii, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Calcium; Cholecystokinin; Intracellular calcium mobilization; Panic disorder; Protein kinase C; T cell

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CALCIUM; CALYCULIN A; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; LORGLUMIDE; PD 135158; PENTAGASTRIN; PROGLUMIDE; PROTEIN KINASE C; STAUROSPORINE; TETRAGASTRIN;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0029977625     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66041610.x     Document Type: Article

References (36)

1. 2c receptors. J. Neurochem. 64, 2473-2479.
2. American Psychiatric Association (1987) DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd edit., revised. American Psychiatric Association, Washington, D.C.
3. Aune T. M., Kelley K. A., Ranges G. E , and Bombara M. P. (1990) Serotonin-activated signal transduction via serotonin receptors on Jurkat cells. J. Immunol. 145, 1826-1831.
4. Beinfelt M. C. and Palkovits M. (1981) Distribution of cholecystokinin in the hypothalamus and the limb system of the rat. Neuropeptide 2, 123-129.
5. Bock M. G., Dispardo R. M., Evans B. E., Rittle K. E., Whitter W. L., Veber D.F., Anderson P. S., and Freidinger R. M. (1989) Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. J. Med. Chem. 32, 13-16.
6. Bouthillier A. and de Montigny C. (1988) Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat. Eur. J. Pharmacol. 151, 135-138.
7. Bradwejn J. and de Montigny C. (1984) Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature 312, 363-364.
8. Bradwejn J., Koszycki D., and Meterissian G. (1990) Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorder. Can. J. Psychiatry 35, 83-85.
9. Bradwejn J., Koszycki D., and Shriqui C. (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Arch. Gen. Psychiatry 48, 603-610.
10. Bradwejn J., Koszycki D., du Tertre A. C., van Megen H., den Boer J., Westenberg H., and Annable L. (1994) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch. Gen. Psychiatry 51, 486-493.
11. Brambilla F., Bellodi L., Perna G., Garberi A., Panerai A., and Sacerdote P. (1993) T cell cholecystokinin concentrations in panic disorder. Am. J. Psychiatry 150, 1111-1113.
12. Brodde O.-E., Kretsch R , Ikezono K., Zerkowski H.-R., and Reidemeister J. C. (1986) Human beta-adrenoceptors: relation of myocardial and T cell beta-adrenoceptor density. Science 231, 1584-1585.
13. Brodin K., Ogren S. V., and Brodin E. (1994) Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions. Eur. J. Pharmacol. 263, 175-180.
14. Chang R. S. L. and Lotti V. J. (1986) Biochemical characterization of an extremely potent and selective nonpeptide CCK antagonist. Proc. Natl. Acad. Sci. USA 38, 4923-4926.
15. Csonka E., Fekete M., Nagy G., Szanto-Fekete M., Feledyg G., Penke B., and Kovacs K. (1988) Anxiogenic effect of cholecystokinin in rats, in Peptides (Penke B. and Torok A., eds), pp. 249-252. Walter de Gruyter & Co., New York.
16. Dal Forno G., Pietra C., Urciuoli M., Van Amsterdam F. T. M., Toson G., Gaviraghi G., and Trist D. (1992) Evidence for two CCK receptors mediating contraction of guinea-pig ileum longitudinal muscle myenteric plexus. J. Pharmacol. Exp. Ther. 261, 1056-1063.
17. de Montigny C. (1989) Cholecystokinin tetrapeptide induces panic like attacks in healthy volunteers. Arch. Gen. Psychiatry 46, 511-517.
18. Fourmy D., Zahidi A., Fabre R., Guidet M., Pradayrol L., and Ribet A. (1987) Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. Eur. J. Biochem. 165, 683-692.
19. Geissler J F., Traxler P., Regenass U., Murray B. J., Roesel J. L., Meyer T., McGlynn E., Storni A., and Lydon N. B. (1990) Thiazolidine-diones; biochemical and biological activity of a novel class of tyrosine protein kinase inhibitor. J. Biol. Chem. 265, 22255-22261.
20. Gordon M., Cohen J. J., and Wilson B. I (1978) Muscarinic cholinergic receptors in murine T cells: demonstration by direct binding. Proc. Natl. Acad. Sci. USA 75, 2902-2904.
21. Harro J., Lang A., and Vasar E. (1990) Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur. J. Pharmacol. 180, 77-83.
22. Harro J., Marcusson J., and Oreland L. (1992) Alterations in brain cholecystokinin receptors in suicide victims. Eur. Neuropsychopharmacol. 2, 57-63.
23. Hill D. R., Campbell N. J., Shaw T. M., and Woodruff G. N. (1987) Autoradiographic localization and biochemical characterization of peripheral-type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7, 2967-2976.
24. Ishihara H., Martin B. L., Brautigan D. L., Karaki H., Ozaki H., Kato Y., Fusetani N., Watabe S., Hashimoto K., Uemura D, and Hartshorne D. J. (1989) Calyculin C and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159, 871-877.
25. 1 increase but not PKC activation in Jurkat T-cells. Neuroreport 3, 697-699.
26. Kopin A. S., Lee Y.-M., McBride E. W., Miller L. J., Lu M., Lin H. Y., Kolakowski L. F. Jr., and Beinborn M. (1992) Expression cloning and characterisation of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA 89, 3605-3609.
27. B antagonist, in panic disorder. Biol. Psychiatry 37, 462-466.
28. Lignon M. F., Bernad N., and Martinez J. (1991) Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line. Mol. Pharmacol. 39, 615-620.
29. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur. J. Pharmacol. 245, 241-246.
30. Lin C. W., Holiday M. W., Barrett R. W., Wolfram C. A. W., Miller T. R., Witte D., Kerwin J. F. Jr., and Nadzan A. M. (1989) Distinct requirements for activation at CCK-A and CCK-B/ gastrin receptors: studies with C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Mol. Pharmacol. 36, 881-886.
31. Lydiard R. B., Ballenger J. C., Laraia M. T., Fossey M. D., and Beinfeld M. C. (1992) CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am. J. Psychiatry 149, 691-693.
32. Pisegna J. R., de Weerth A., Huppi K., and Wank S. A. (1992) Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem. Biophys. Res. Commun. 189, 296-303.
33. Schiffman S. N. and Van der Haeghen J. J. (1991) Distribution of cells containing mRNA encoding cholecystokinin in the rat central nervous system. J. Comp. Neurol. 304, 219-233.
34. Strom B. T., Lane A. M., and George K. (1981) The parallel, time-dependent, bimodal change in T cell cholinergic binding activity and cholinergic influence upon T cell-mediated cytotoxicity after T cell activation. J. Immunol. 127, 705-710.
35. Wank S. A., Pisegna J. R., and Weerth A. D. (1992) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc. Natl. Acad. Sci. USA 89, 8691-8695.
36. Woodruff G. N. and Hughes J. (1991) Cholecystokinin antagonists. Annu. Rev. Pharmacol. Toxicol. 31, 469-501.